UBS Group AG - ARTELO BIOSCIENCES INC ownership

ARTELO BIOSCIENCES INC's ticker is ARTL and the CUSIP is 04301G201. A total of 18 filers reported holding ARTELO BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARTELO BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$16,000
+100.0%
48,961
+167.8%
0.00%
Q1 2022$8,000
-81.4%
18,283
-49.8%
0.00%
Q2 2021$43,000
+65.4%
36,431
+132.4%
0.00%
Q1 2021$26,000
+2500.0%
15,675
+1861.8%
0.00%
Q1 2020$1,000
-87.5%
799
-78.0%
0.00%
Q3 2019$8,0003,6300.00%
Other shareholders
ARTELO BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
KEYSTONE WEALTH PARTNERS 15,000$7,0000.00%
Snowden Capital Advisors LLC 110,000$49,0000.00%
Virtu Financial LLC 23,801$11,0000.00%
UBS Group AG 18,283$8,0000.00%
WELLS FARGO & COMPANY/MN 260$00.00%
NORTHERN TRUST CORP 62,521$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 167,826$75,0000.00%
STATE STREET CORP 13,039$6,0000.00%
CREATIVE FINANCIAL DESIGNS INC /ADV 1,075$00.00%
View complete list of ARTELO BIOSCIENCES INC shareholders